Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick A Lewis

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Journal of Neurochemistry|September 17, 2015
Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brainLaura Civiero, Maria Daniela Cirnaru, Alexandra Beilina, et al.
Molecular Neurodegeneration|August 27, 2015
Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutationAoife P Kiely, Helen Ling, Yasmine T Asi, et al.
The EMBO Journal|May 24, 2018
LRRK2 is a negative regulator of <i>Mycobacterium tuberculosis</i> phagosome maturation in macrophagesAnetta Härtlova, Susanne Herbst, Julien Peltier, et al.
Nature Neuroscience|August 13, 2013
The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagyVictoria S Burchell, David E Nelson, Alvaro Sanchez-Martinez, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Microglia produce the amyloidogenic ABri peptide in familial British dementiaCharles Arber, Jackie M Casey, Samuel Crawford, et al.
Acta Neuropathologica|November 15, 2024
Microglia contribute to the production of the amyloidogenic ABri peptide in familial British dementiaCharles Arber, Jackie M Casey, Samuel Crawford, et al.
Plos Medicine|June 14, 2017
Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation studyAlastair J Noyce, Demis A Kia, Gibran Hemani, et al.
Neurogenetics|November 19, 2013
Rare variants in LRRK1 and Parkinson's diseaseEva C Schulte, Daniel C Ellwanger, Sybille Dihanich, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 28, 2023
Artificial intelligence for neurodegenerative experimental modelsSarah J Marzi, Brian M Schilder, Alexi Nott, et al.
Plos One|July 30, 2011
Pathogenic LRRK2 mutations do not alter gene expression in cell model systems or human brain tissueMichael J Devine, Alice Kaganovich, Mina Ryten, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Journal of Neurochemistry|September 17, 2015
Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brainLaura Civiero, Maria Daniela Cirnaru, Alexandra Beilina, et al.
Molecular Neurodegeneration|August 27, 2015
Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutationAoife P Kiely, Helen Ling, Yasmine T Asi, et al.
The EMBO Journal|May 24, 2018
LRRK2 is a negative regulator of <i>Mycobacterium tuberculosis</i> phagosome maturation in macrophagesAnetta Härtlova, Susanne Herbst, Julien Peltier, et al.
Nature Neuroscience|August 13, 2013
The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagyVictoria S Burchell, David E Nelson, Alvaro Sanchez-Martinez, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Microglia produce the amyloidogenic ABri peptide in familial British dementiaCharles Arber, Jackie M Casey, Samuel Crawford, et al.
Acta Neuropathologica|November 15, 2024
Microglia contribute to the production of the amyloidogenic ABri peptide in familial British dementiaCharles Arber, Jackie M Casey, Samuel Crawford, et al.
Plos Medicine|June 14, 2017
Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation studyAlastair J Noyce, Demis A Kia, Gibran Hemani, et al.
Neurogenetics|November 19, 2013
Rare variants in LRRK1 and Parkinson's diseaseEva C Schulte, Daniel C Ellwanger, Sybille Dihanich, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 28, 2023
Artificial intelligence for neurodegenerative experimental modelsSarah J Marzi, Brian M Schilder, Alexi Nott, et al.
Plos One|July 30, 2011
Pathogenic LRRK2 mutations do not alter gene expression in cell model systems or human brain tissueMichael J Devine, Alice Kaganovich, Mina Ryten, et al.
Pageof 12